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Diacylglycerol is necessary for trans-Golgi network (TGN) to cell surface transport, but its functional relevance in the
early secretory pathway is unclear. Although depletion of diacylglycerol did not affect ER-to-Golgi transport, it led to a
redistribution of the KDEL receptor to the Golgi, indicating that Golgi-to-ER transport was perturbed. Electron micros-
copy revealed an accumulation of COPI-coated membrane profiles close to the Golgi cisternae. Electron tomography
showed that the majority of these membrane profiles originate from coated buds, indicating a block in membrane fission.
Under these conditions the Golgi-associated pool of ARFGAP1 was reduced, but there was no effect on the binding of
coatomer or the membrane fission protein CtBP3/BARS to the Golgi. The addition of 1,2-dioctanoyl-sn-glycerol or the
diacylglycerol analogue phorbol 12,13-dibutyrate reversed the effects of endogenous diacylglycerol depletion. Our
findings implicate diacylglycerol in the retrograde transport of proteins from Golgi to the ER and suggest that it plays a
critical role at a late stage of COPI vesicle formation.
INTRODUCTION
Recent observations from several laboratories indicate that
membrane lipids regulate intracellular membrane transport,
particularly in distal stages of the secretory pathway. Diac-
ylglycerol (DAG) is a simple and small sized signal-trans-
ducing lipid which among other functions is necessary for
protein transport from the Golgi complex to the cell surface
both in yeast and in mammals. Thus, in budding yeast
phosphatidylinositol (PI)-transfer Sec14p protein directly
regulates DAG homeostasis in the Golgi complex and protein
secretion (Bankaitis et al., 1990; Kearns et al., 1997; Huijbregts et
al., 2000). In mammals, the reduction of DAG levels at the Golgi
caused by the depletion of Nir2 (a peripheral Golgi protein
containing a PI-transfer domain) inhibits post-Golgi protein
transport (Litvak et al., 2005). DAG acts in the trans-Golgi
network (TGN) as a membrane acceptor for specific proteins
such as the protein kinase C (PKC) family member PKD/
PKC (Prestle et al., 1996; Liljedahl et al., 2001; Baron and
Malhotra, 2002), and Hmun13 (Speight and Silverman, 2005).
PKD together with PKC, the trimeric G-protein subunits /
(Dı´az Anel and Malhotra, 2005), and phosphatidylinositol-4
kinase III (Hausser et al., 2005) directly participate in the
post-Golgi transport of plasma membrane proteins containing
basolateral sorting information (Yeaman et al., 2004). On the
other hand, Hmun13, through the recruitment of Rab34, par-
ticipates in the Golgi-lysosome protein trafficking (Speight and
Silverman, 2005). DAG also promotes the Golgi membrane
targeting and activation of other C1 domain-containing signal-
ing molecules such as other PKC isoforms (PKC, PKC, and
PKC; Maissel et al., 2006; Lehel et al., 1995; Wang et al., 1999,
respectively) and Ras guanosine nucleotide-releasing proteins
(RasGRPs; Caloca et al., 2003), whose potential involvement in
Golgi-associated transport functions remains unexplored.
The aforementioned Golgi-associated transport events linked to
DAG levels can be envisioned in the framework of the DAG-
phosphatidic acid (PA) interconversion. Thus, DAG is formed
by phosphatidic acid phosphohydrolases (PAPs)—also known
as lipid phosphate phosphatases (LPPs), and PA results from
the activity of the DAG-consuming kinases (DAGKs). Al-
though there are many DAGK isoforms, only DAGK and
DAGK have been localized to biosynthetic compartments
such as the TGN (Alonso et al., 2005) and the endoplasmic
reticulum (ER; Nagaya et al., 2002), respectively. To date only
the PAP2b isoform has been located in the Golgi complex but
in a cell-type–dependent manner (Sciorra and Morris, 1999).
PA is formed by de novo synthesis from glyceraldehyde-3-
phosphate or dihydroxyacetone-phosphate and acylCoAs and
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also by breakdown of other phospholipids, in particular by the
activity of phosphatidylcholine (PC)-specific phospholipase D
enzymes (PLDs). Mammalian PLD1 (and PLD2, although this
is controversial) is located in Golgi membranes (Freyberg et al.,
2001, 2002), supporting previous observations that indicated a
direct role of PA in vesicle coat recruitment and budding
(Siddhanta and Shields, 1998), as a result of ARF1-dependent
enhancement of the PLD activity in the Golgi complex (Chen et
al., 1997). Therefore, PLD and PAP act in series to generate PA
and DAG in (endo)membranes. Moreover, DAG is also gener-
ated through the action of sphingomyelin synthase (SMS),
which is responsible for sphingomyelin (SM) and DAG forma-
tion (Ichikawa and Hirabayashi, 1998). In fact, one of the two
SMS isoforms (SMS1) acts in the Golgi lumen (Huitema et al.,
2004). Another source of DAG in the Golgi are phosphoinositi-
des. Thus, phosphatidylinositol-4-phosphate (PI,4P/PIP) or
phosphatidylinositol 4,5-biphosphate (PI4,5P2/PIP2) is con-
verted to DAG and inositol bis- or Tris-phosphate through
phosphoinositide-specific phospholipase C (PI-PLC; Claro et
al., 1993; Rhee, 2001). In the plasma membrane and the Golgi
apparatus, PLC acts as a phosphoinositide-specific PLC
(Satoh et al., 2005). In the Golgi apparatus, the main phospho-
inositide is PIP, which is actively generated by two phospha-
tidylinositol 4-kinases (PI4Ks) localized to the Golgi complex in
mammalian cells (type III PI4K and type II PI4K; Wang et al.,
2003; Weixel et al., 2005). In contrast, PIP2 at the Golgi is present
at very low concentrations (De Matteis and Godi, 2004).
On the other hand, apart from functioning as a signaling
molecule, the special biophysical properties of DAG may come
into play (Leikin et al., 1996; Gon˜i and Alonso, 1999). DAG has
a small and electrically neutral polar head, explaining its pro-
nounced cone shape and its capacity to undergo rapid trans-
bilayer movement. DAG may induce membrane bending and
facilitate the formation of highly curved membrane intermedi-
ates, thereby enhancing membrane constriction (Shemesh et al.,
2003) and fusion (Chernomordik et al., 1995).
The potential coupling between the DAG-PA interconver-
sion and CtBP3/BARS (BARS50) is of particular interest
(Corda et al., 2006) as this fission protein has recently been
implicated in the biogenesis of COPI (coatomer)-coated
(Yang et al., 2005) and constitutive post-Golgi (Bonazzi et al.,
2005) transport carriers. BARS-dependent membrane fission
requires long-chain acylCoAs and it was originally pro-
posed to form PA by adding an acyl chain to lypophospha-
tidic acid (Weigert et al., 1999; see also Gallop et al., 2005).
Alternatively, BARS may collaborate with lipid enzymes
such as PLD, whose activity is required for numerous fission
and membrane dynamics events (Tuscher et al., 1997; Roth et
al., 1999; Freyberg et al., 2003; Pathre et al., 2003; Lee et al.,
2006). Like DAG, PA has special biophysical properties, and
recent data indicate that PA could act as a docking site for
interfacial insertion of positively charged membrane protein
domains (Kooijman et al., 2003, 2007), which with a PA-DAG
interconversion cycle could be crucial for final membrane
constriction/fission of coated/noncoated transport vesicles.
In this respect, ARFGAP1 (ADP-ribosylating factor GTPase-
activating protein) plays a central role in coupling cargo
sorting and COPI vesicle formation on Golgi membranes by
catalyzing GTP hydrolysis in the small G protein ARF1 (Lee
et al., 2005). ARFGAP1 constitutes a structural component of
the COPI coat, and it contains a central motif named ALPS
(ARFGAP1 lipid-packing sensor) that adsorbs preferentially
onto highly curved membranes. This motif may allow the
rate of GTP hydrolysis in ARF1 to be coupled with the
membrane curvature induced by the COPI coat, which may
lead to ARFGAP1 to function as a curvature sensor or in-
ducer protein (Holthuis and Burger, 2003; Bigay et al., 2005).
Although the molecular details of its Golgi targeting are
unknown, a combination of interactions between transmem-
brane proteins and the COPI coat and lipids has been pos-
tulated (Antonny et al., 1997; Bigay et al., 2003; Mesmin et al.,
2007).
Here, we test the hypothesis that DAG regulates mem-
brane trafficking at the ER–Golgi interface. We used a vari-
ety of pharmacological compounds that compromise cellu-
lar DAG production. Briefly, we found that the decrease of
Golgi-associated DAG levels inhibits retrograde (Golgi-to-
ER) but not anterograde (ER-to-Golgi) protein transport,
reduces the ARFGAP1 pool in the Golgi complex and in-
creases the amount of COPI-coated buds. These findings
indicate that DAG participates in the fission of COPI trans-
port carriers derived from early Golgi compartments.
MATERIALS AND METHODS
Reagents, Antibodies, and Plasmids
Brefeldin A (BFA), fumonisin B1 (FB1), O-tricyclo [5.2.1.02,6]dec-9-yl dithio-
carbonate potassium salt (D609), 2-dioctanoyl-sn-glycerol (DOG), phorbol
12-myristate 13-acetate (PMA), phorbol 12,13-dibutyrate (PDBu), anti-VSV-G
P5D4, anti--tubulin, anti-Flag monoclonal antibodies, and TRITC (tetram-
ethylrhodamine isothiocyanate)-phalloidin were purchased from Sigma (St.
Louis, MO). Latrunculin B, nocodazole, propanolol, U73122, and Mowiol
were from Calbiochem (San Diego, CA). Rabbit polyclonal antibodies against
the KDEL receptor (KDELr), galactosyltransferase (GalT), and manosidase II
(ManII) were kindly provided by the late H.-D. So¨ling (University of Go¨tingen),
E. Berger (University of Zu¨rich), and K. Moremen (University of Georgia, Ath-
ens), respectively. Mouse monoclonal antibodies to giantin, -COP, and CTR433
were provided by H.-P. Hauri (Biozentrum, Basel), F. Wieland (University of
Heidelberg) and M. Bornens (Institute Curie), respectively. mAb to BARS was
both provided by A. Luini (Consorzio Mario Negri Sud CMNS, Chieti, Italy)
and purchased from BD Transduction Laboratories (San Diego, CA). Second-
ary antibodies conjugated to Cy3- or fluorescein isothiocyanate (FITC)-
F(ab)2 fragments were from Jackson InmunoResearch Laboratories (West
Grove, PA). Plasmids encoding EGFP-C1b-PKC and EGFP-ARFGAP1 were
from I. Merida (Consejo Superior de Investigaciones Cientı´ficas, Madrid) and
H. Gad (CMNS, Chiety), respectively. Unless otherwise stated, all other
chemicals were from Sigma.
Cell Lines and Cell Culture
COS-1, NRK, Vero, and HeLa cells, including stable HeLa cells that constitutively
express YFP-GalT or GST-Flag-PKD-KD (a gift of V. Malhotra, University of
California, San Diego, CA), were cultured in DMEM (Invitrogen, Paisley, United
Kingdom) containing 10–20% of fetal calf serum (FCS; GIBCO/BRL Invitrogen,
Paisley, United Kingdom). HeLa spinner cells were cultured in RPMI 1640
(Biochrom, Berlin, Germany) containing 7.5% FCS. All culture media were sup-
plemented with sodium pyruvate (1 mM), glutamine (2 mM), penicillin (100
U/ml), and streptomycin (100 g/ml). Cells were grown in a humidified incu-
bator in 5% CO2 at 37°C.
Isolation of Golgi Membranes
Golgi fractions from HeLa cells were prepared at 4°C following a modification of
the method established by Balch et al. (1984). Hela spinner cells were grown in
suspension, and they reached a 5  108 cells were treated either with propanolol
or U73122. They were harvested by centrifugation (10 min at 500  g), washed
twice with PBS (10 min at 500  g), twice with homogenization buffer (250 mM
sucrose in 10 mM Tris-HCl, pH 7.4; 10 min at 1,500  g), resuspended in four
volumes of homogenization buffer. Thereafter, cells were homogenized using the
Ball-Balch homogenizer device. The homogenate was brought to a sucrose con-
centration of 37% (wt/wt) by the addition of 62% (wt/wt) sucrose in 10 mM
Tris-HCl, pH 7.4, and EDTA (1 mM, final concentration). Twelve milliliters of this
solution was placed at the bottom of a SW 28 tube and carefully overlaid with 15
ml of sucrose at 35% (wt/wt) and 9 ml sucrose at 29% (wt/wt) in 10 mM Tris-HCl
(pH 7.4). Gradients were centrifuged at 25,000 rpm for 2.5 h. Golgi-enriched
membrane fraction were recovered at the 35–29% sucrose interphase and subse-
quently frozen in aliquots in liquid nitrogen and stored at 80°C. Protein con-
centration was determined using the Bradford assay.
Diacylglycerol Content
Golgi membrane lipids from control and propanolol- or U73122-treated cells
were extracted in glass tubes with chloroform/methanol/HCl (Bligh and
Dyer, 1959). To determine diacylglycerol content in these lipid extracts, quan-
titative conversion to [32P]phosphatidic acid by diacylglycerol kinase was
performed as described (Preiss et al., 1987). Chloroform extracts (850 l) of
isolated Golgi membranes (70 g) or 1-stearoyl-2-arachidonoyl-sn-glycerol
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(Sigma) samples (30–500 pmol) were evaporated under a gentle stream of
nitrogen, and the dried lipids were solubilized in 20 l of 7.5% octyl--d-
glucoside, 5 mM cardiolipin, and 1 mM diethylenetriaminepentaacetic acid
(DETAPAC) by sonication in a bath (50–60 Hz) for 30 s, after incubation for
10 min at room temperature. To this lipid solution, we added 50 l of 100 mM
imidazole/HCl buffer, pH 6.6, containing 100 mM NaCl, 25 mM MgCl2, and
2 mM EGTA, and then 10 l of fresh 20 mM dithiothreitol (DTT) in 1 mM
DETAPAC, pH 7.0, and 10 l of a diacylglycerol kinase (Calbiochem) solution
(0.25 mg/ml) in 20 mM imidazole/HCl buffer, pH 6.6, containing 2 mM
DETAPAC. The reaction was started by adding 10 l of 100 mM imidazole/
HCl buffer, pH 6.6, containing 1 mM DETAPAC, 10 mM ATP, and 0.6 Ci
[-32P]ATP (Amersham Pharmacia Biotech, Piscataway, NJ, 3 Ci/mmol, 2
mCi/ml), and was carried out for 30 min at room temperature. Reactions
were stopped with 0.6 ml of chloroform/methanol/10 M HCl (100:200:1 by
vol), followed by addition of 0.25 ml each of water and chloroform, in order
to split two phases. The lower (chloroform) phases were washed with chlo-
roform-saturated methanol/water (1:1), evaporated under nitrogen, dis-
solved in 20 l of chloroform/methanol (4:1), and developed on silica gel 60
thin-layer chromatography (TLC) plates using chloroform/methanol/acetic-
acid/water (100:60:16:8; vol/vol/vol/vol) and air-dried. [32P]Phosphatidic
acid was quantified using PhosphorImager (Molecular Dynamics, Sunnyvale,
CA) and NIH Image software.
Transient Transfections
Cells were grown to 70–80% confluence and then transfected either with
EGFP-C1b-PKC or GFP-ARFGAP1 using the Effectene transfection method
(Qiagen, Valencia, CA) according to the manufacturer’s instructions. Unless
otherwise indicated, experiments were carried out 12–16 h after transfection.
Cells expressing EGFP-C1b-PKC or GFP-ARFGAP1 for confocal microscopy
were treated with cycloheximide (100 g/ml) 60 min before the assay.
VSV-G Infection and VSV-G Transport Assay
Experiments were carried out as previously indicated (Valderrama et al., 1998).
Immunofluorescence and Quantitative Image Analysis
Indirect immunofluorescence assays were carried out using the following
antibody dilutions: anti-KDELr, 1:1000; anti-Gal-T, 1:100; anti-giantin, 1:500; anti-
ManII, 1:1000; anti--COP 1:1000; anti--tubulin, 1:50; anti-BARS, 1:50;
anti-VSV-G, 1:50; anti-Flag, 1:1000; anti-CTR433, 1:5; Cy3-anti-mouse, 1:50;
anti-mouse-FITC, 1:100; and anti-rabbit-Cy3– and anti-rabbit-FITC–conju-
gated secondary antibodies, 1:250. Immunostained coverslips were mounted
on microscope slides using Mowiol. Microscopy and imaging were performed
either with an Olympus BX60 epifluorescence microscope equipped with a
cooled Olympus CCD camera (Lake Success, NY) or with a Leica TCS-NT
confocal microscope (Heerbrugg, Switzerland). The images were processed
using Image J software. To quantify cytoplasmic fluorescent punctuate struc-
tures containing KDELr, eight-bit gray scale nonsaturated images were set at
an arbitrary threshold value of 90. For each cell, the number of stained
structures (defined as being smaller than 600 pixels) over threshold was
scored covering the total cytoplasmic area.
Time-Lapse Fluorescence Confocal Microscopy
Time-lapse fluorescence confocal microscopy experiments were carried out
using a Leica TCS SL laser-scanning confocal spectral microscope (Leica
Microsystems Heidelberg, Manheim, Germany) with Argon and HeNe lasers
attached to a Leica DMIRE2 inverted microscope equipped with an incuba-
tion system with temperature and CO2 control. For visualization of GFP,
images were acquired using a PL APO 63 oil immersion objective lens (NA
1.32), 488-nm laser line, excitation beam splitter RSP 500, and an emission
range detection: 500–610 nm and the confocal pinhole set at 4.94 Airy units.
Images were acquired at 30-s intervals for 1–2 h, and optical sectioning was
necessary to capture the whole signal. The excitation intensity was attenuated
to 5% of the half-laser power to avoid significant photobleaching. Image
treatment and movie assembly were performed using the Image Processing
Leica Confocal Software. PMA (250 nM) was added to DMEM after the first
frame, and images were recorded every 15 s. Then, after the forty-first frame,
DOG (3 M) or PDBu (250 nM) was mixed with PMA. Propranolol (60 M)
and DOG (3 M) were added to DMEM after the first frame. Cells were
preincubated with DOG (3 M, 15 min) and then mixed with propanolol, and
images were recorded every 15 s. BFA (5 g/ml), propanolol (60 M), or BFA
together with propranolol was added to the DMEM in the same conditions,
but in this case images were recorded every 10 s. Films and time series of
fluorescent images taken from films were processed using Image J software.
Electron Microscopy, Electron Tomography, and 3D
Modeling
For transmission electron microscopy (TEM), Vero, NRK, and HeLa cells were
rapidly fixed with 1.25% glutaraldehyde in PIPES buffer (0.1 M, pH 7.4)
containing sucrose (2%) and Mg2SO4 (2 mM) for 60 min at 37°C. Cells were
then gently scraped, pelleted at 100  g for 10 min, rinsed in PIPES buffer (3 
5 min), and postfixed with 1% (wt/vol) OsO4, 1% (wt/vol) K3Fe(CN)6 in
PIPES buffer for 1 h at room temperature in the dark. Cells were then treated
for 5 min with tannic acid (0.1%) in PIPES buffer, rinsed in distilled water,
block-stained with 1% uranyl acetate in 70% ethanol for 1 h, dehydrated with
graded ethanol solutions, and finally embedded in Epon plastic resin (EMS,
Hatfield, PA). Ultrathin sections (50–70-nm thick) were stained with lead
citrate and observed on a JEOL 1010 electron microscope (Peabody, MA).
Micrographs of randomly selected areas were obtained with a Gatan Bioscan
digital camera (Pleasanton, CA) at the same final magnification (50,000) and
analyzed using point-counting procedures. The stereological parameters were
determined using standard procedures. The minimum sample size of each
stereological parameter was determined by the progressive mean technique
(confidence limit of 5%). The results were expressed as means  SD and
compared using Student’s t test.
For electron tomography and 3D modeling, sections (250 nm) of chemically
fixed, Epon-embedded NRK cells were transferred to Butvar-coated copper
slot grids. Colloidal gold particles (10 nm) were added to one side of the grid
as markers to align the series of tilted images. Tilt series of representative
Golgi stacks were automatically recorded (Ziese et al., 2002) at 200 kV using
a Tecnai20 electron microscope (FEI/Philips Electron Optics, Eindhoven, The
Netherlands) equipped with a slow-scan CCD camera (TemCam F214, TVIPS
[Tietz Video and Image Processing Systems], Gauting, Germany) and a mo-
torized goniometer. Recording was made with Xplore 3D software package;
FEI) at a final magnification of 14,000. Every specimen was tilted about two
orthogonal axes from 65° to 65° at 1° intervals, resulting in two datasets of
131 high-resolution digital images. Images were then aligned using the pro-
gram package IMOD (Kremer et al., 1996), and a tomogram was computed
from each tilt series. The two single-axis tomograms were merged into one
(Mastronade, 1997), and the tomographic dual-axis reconstruction was inter-
preted and modeled using IMOD software.
Statistical Analysis
For statistical computation and estimation of significance, we used the online
software GraphPad (San Diego, CA; www.graphpad.com). Control and differ-
ently treated cells were run through unpaired ANOVA and, when appropriate,
Student’s t test.
RESULTS
Both Propanolol and U73122 Reduced DAG Levels in the
Golgi Complex
To study the role of DAG in protein transport at the ER–Golgi
interface, we examined a range of pharmacological agents (Fig-
ure 1) that had been reported to decrease DAG levels in a wide
variety of cell types. These compounds are as follows: 1) pro-
panolol, which inhibits PAP and therefore prevents dephos-
phorylation of PA to DAG (Pappu and Hauser, 1983; Roberts et
al., 1998; Baron and Malhotra, 2002); 2) D609, which inhibits
PC-specific PLC (Schutze et al., 1992; Exton, 1994) and SMS1
(Luberto and Hannun, 1998); 3) U73122, which inhibits PI-PLC
(Bleasdale et al., 1990; Thompson et al., 1991; Jun et al., 2004);
and 4) FB1, which inhibits ceramide synthase and thus de-
prives SM synthase of substrate and lowers DAG (Wang et al.,
1991; Wu et al., 1995; Merrill et al., 2001). First, we examined
whether these compounds perturb the organization and dy-
namics of microtubular and actin cytoskeletons, because an
efficient ER–Golgi interface membrane trafficking is dependent
on the integrity of both cytoskeletons (Murshid and Presley,
2004; Egea et al., 2006). NRK and Vero cells treated with pro-
panolol (60 M/30 min), U73122 (6 M/30 min), D609 (500
M/30 min), or FB1 (25 gml1/24 h) showed microtubule
and actin cytoskeleton organization (Supplementary Figure
1A) and dynamics (Supplementary Figure 1, B and C) that was
indistinguishable from control. However, D609 blocked the
reconstitution of microtubules (Supplementary Figure 1B) and
actin filaments (unpublished data) that was expected after the
respective removal of nocodazole and latrunculin B. Conse-
quently, we ruled out the use of D609.
We then examined the effects of propanolol, U73122, and
FB1 on the DAG pool in the Golgi complex. We used the
concentrations stated above, so that the cytoskeleton would
not be compromised. We used 1) the inactive mutant form of
PKD (PKD-K618N/PKD-KD), 2) a biochemical assay to
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measure DAG levels in Golgi fractions isolated from treated
cells, and/or 3) the DAG-dependence localization of the C1
domain of PKC in the Golgi (see below). With respect to the
former approach, it is known that DAG is sufficient and
necessary for the recruitment of PKD to TGN membranes
(Maeda et al., 2001). Thus, the HeLa stable cell line express-
ing GST-flag-PKD-KD was treated with propanolol, U73122,
or FB1. After 15 min of treatment with propanolol (Figure 2,
C and D), U73122 (Figure 2, G and H), or FB1 (unpublished
data; see Baron and Malhotra, 2002), PKD-KD was redistrib-
uted from the Golgi to the cytoplasm. Moreover, PKD-KD
returned to the Golgi when propanolol (Figure 2, E and F),
U73122, or FB1 (unpublished data) was washed out. We also
measured DAG in Golgi membranes isolated from HeLa
cells treated with propanolol or U73122. Both propanolol
and U73122 decreased DAG levels to45% of control values
(Figure 2I). In addition, FB1 (as well as propanolol and
U73122) induced the complete redistribution of the GFP-C1b
domain of PKC from the Golgi to the cytoplasm (Supple-
mentary Figure 3B and see below). This is indicative of a
robust decrease of the DAG pool in the Golgi caused by FB1
treatment. Therefore, propranolol, U73122, and FB1 dimin-
ished Golgi-associated DAG levels without altering the or-
ganization and dynamics of actin or microtubular cytoskel-
eton. This validates their use in examining the potential
involvement of DAG in membrane trafficking at the ER–
Golgi interface.
Propanolol and U73122 Blocked the Retrograde But Not
Anterograde Membrane Transport
To assess whether the maintenance of DAG levels in the
Golgi is required for ER–Golgi interface membrane traffick-
ing, we examined the ER-to-Golgi transport of VSV-G pro-
tein. Cells were infected with the ts045 VSV mutant, which
Figure 1. Signaling pathways that are most likely to be implicated in
the generation of DAG at the Golgi. Enzymes involved in the produc-
tion of DAG and the inhibitors used in this study are shown. DAG
degradation enzymes and the metabolites generated from this lipid are
omitted for simplicity. Cer, ceramide; CerS, CoA-dependent dihydro-
ceramide/ceramide synthase; DAG, diacylglycerol; DAGK, dicylglyc-
erol kinase; FB1, fumonisin B1; PA, phosphatidic acid; PAP/LPP,
phosphatidic acid phosphatase/lipid phosphate phosphatase; PC,
phospatidylcholine; PI4P, phosphatidylinositol, 4 monophosphate;
PI4,5P2, phosphatidylinositol 4,5-biphosphate; PC-PLC, phosphatidyl-
choline-specific phospholipase C; PI-PLC, phosphoinositides-specific
phospholipase C; PLD, phospholipase D; SM, sphingomyelin; SMS,
sphingomyelin synthase 1; S-1-P, sphingosine-1-phosphate.
Figure 2. Treatment with propranolol or U73122 decrease DAG
levels in the Golgi. HeLa cells that stably express GST-flag-PKD-KD
(K618N) were treated with propanolol (60 M/15 min; C and D) or
U73122 (6 M/15 min; G and H). Thereafter, cells were coimmu-
nostained with a mAb anti-flag to visualize PKD-KD (A, C, E, and
G) and a polyclonal antibody to galactosyltransferase (GalT) to
visualize the Golgi complex (B, D, F, and H). Note that the
treatment with propanolol (C) or U73122 (G) induced the redis-
tribution of PKD-KD from the Golgi (A) to the cytosol (C and G).
When propanolol was removed from the culture medium (45 min),
the PKD-KD redistributed in the cytosol was returned to the Golgi
(E and F). (I) DAG content of isolated Golgi membranes from
untreated (control), propanolol (60 M/15 min)-, or U73122 (6
M/15 min)-treated HeLa cells measured by the DAG-kinase assay.
Statistical significance, *p 	 0.05. Bar, 10 m.
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at nonpermissive temperature (40°C) was retained at the ER
(Supplementary Figure 2A). When cells were transferred to
permissive temperature (32°C), VSV-G was transported to
the plasma membrane (Supplementary Figure 2C) crossing
the Golgi complex (Supplementary Figure 2B). When VSV-
infected cells were treated with propanolol, U73122, or FB1,
VSV-G transport from the ER to the Golgi was unaltered
(Supplementary Figure 2, E, H, and K, respectively). In
accordance with these results, neither propanolol nor
U73122 (unpublished data) nor FB1 (Supplementary Figure
3) affected the normal reassembly of the Golgi in BFA
washed-out cells. Interestingly, the VSV-G post-Golgi trans-
port to the plasma membrane was blocked only in propano-
lol- and FB1-treated cells (Supplementary Figure 2, F and L,
respectively) but not in those cells treated with U73122
(Supplementary Figure 2I).
Next, we examined the effect of low DAG in the Golgi on
Golgi-to-ER transport. When propanolol, U7312,2 or FB1
was added subsequently to BFA, the Golgi disassembly
occurred normally (unpublished data). Conversely, when
BFA was added either at the same time as, or just after, the
pretreatment with propanolol or U73122, the redistribution
of Golgi markers (Figure 3, A–D) to the ER was blocked.
Strikingly, FB1 had no effect on the normal Golgi disassem-
bly produced by BFA (Supplementary Figure 3A). Thus,
unlike FB1, propanolol and U73122 perturb the Golgi-to-ER
membrane flow. To confirm this result in a more physiolog-
ical setting, we examined the subcellular distribution of the
KDELr. KDELr mediates the return to the ER of ER-resident
proteins that have escaped to the Golgi. At steady state,
KDELr was observed both in the Golgi and in numerous
punctate cytoplasmic structures, which represent tubulove-
sicular structures that are continuously cycling between the
ER and the Golgi (Figure 3E). Any modification of this
distribution reflects an alteration in the retrograde or antero-
grade traffic rates (Lewis and Pelham, 1992). In Vero cells
treated with propanolol (Figure 3F) or U73122 (Figure 3G),
KDELr staining was reduced in cytoplasmic fluorescent
punctate structures (Figure 3H). Similar morphological fea-
tures were also observed in NRK and HeLa cells (unpub-
lished data). Moreover, morphological alterations were
more robust in propanolol-treated than in U73122-treated
cells (compare quantitative analysis shown in Figures 3, D
and H). Cells treated with FB1 did not show any alteration in
the subcellular distribution of KDELr (unpublished data).
Taken together, our results indicate that only DAG pool(s)
altered by propanolol and U73122 seem to be required for
retrograde (Golgi-to-ER) but not for anterograde (ER-to-
Golgi) membrane trafficking.
It has been postulated that the inhibition by propanolol of
PAP/LPP and the inhibition by U73122 of PI-PLC may
reduce different molecular species of DAG (Carrasco and
Me´rida, 2004). Therefore, we examined whether propanolol
or U73122 have an additive or synergic effect on the Golgi-
to-ER protein transport. Cells were treated with lower con-
centrations of propanolol and U73122 that do not alter BFA-
induced Golgi disassembly (unpublished data) or the
subcellular distribution of KDELr (Supplementary Figures 5,
A and B). When propanolol and U73122 were added to-
gether there was an inhibition of the BFA-induced Golgi-
to-ER membrane backflow (unpublished data) and a change
in the subcellular distribution of the KDELr (Supplementary
Figure 4C). These findings were indistinguishable from
those observed for each compound used separately at higher
Figure 3. Propanolol and U73122 block the BFA-induced Golgi disassembly and alter the steady-state staining pattern of the KDEL receptor.
(A–D) Vero cells were treated with BFA (5 g/ml for 20 min) alone (A), with propanolol (60 M) plus BFA (propanolol was added 5 min
before BFA; B), or U73122 (6 M) plus BFA (U73122 was added 5 min before BFA; C). Cells were then processed for immunofluorescence
microscopy using monoclonal anti-CTR433 to visualize the Golgi complex (see inset in A for control cells). Both propanolol (B) and U73122
(C) blocked the BFA-induced disassembly of the Golgi complex (A). Quantitative analysis of these results is shown in D. (E–H) The
steady-state subcellular distribution of KDEL receptor (KDELr) using anti-KDELr polyclonal antibodies was also examined in control and
propanolol (60 M/60 min; F) or U73122 (6 M/60 min; G)-treated Vero cells. Both propanolol and U73122 treatments induced a significant
change in the steady-state staining pattern of the KDELr: the fluorescent cytoplasmic KDELr-containing punctate structures are no longer
seen. These observations were quantified, as shown in H. Statistical significance, **p 	 0.01 and ***p 	 0.001. Bar, 10 m.
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concentrations (Figure 3, F and G). Next, when cells were
coincubated with the usual working concentrations of pro-
panolol (60 M) plus U73122 (6 M), the change in the
subcellular distribution of KDELr lasted longer than when
the two agents were used separately (120 vs. 60 min). Sim-
ilarly, coincubation resulted in a more persistent inhibition
of BFA-induced Golgi (60 vs. 30 min). Overall, these results
indicate that different pools of DAG participate in Golgi-
to-ER membrane trafficking.
Propanolol and U73122 Perturbed the BFA-induced
Formation of Tubules from Golgi Membranes
Next, we analyzed whether the inhibition of the BFA-medi-
ated redistribution of Golgi membranes to the ER by pro-
panolol and U73122 is the result of the inhibition of BFA-
induced coatomer dissociation. We examined the kinetics of
dissociation of coatomer from Golgi membranes in the pres-
ence of BFA using anti--COP antibodies (Supplementary
Figure 5). Propanolol or U73122 added just before or at the
same time as BFA did not inhibit the BFA-induced dissoci-
ation of coatomer from Golgi membranes (Supplementary
Figure 5, H and K). The distribution of -COP was affected
neither by propanolol nor U73122 (Supplementary Figure 5,
C and E). After the dissociation of coatomer and ARF1 from
Golgi membranes (Klausner et al., 1992), BFA promotes the
formation of Golgi-derived tubules that finally fuse to the
ER. Next we examined whether propanolol and U73122
impair the Golgi tubulation induced by BFA. We used time-
lapse images of Hela cells expressing YFP-tagged GalTase
recorded during the treatment with propanolol or U73122
plus BFA (Figure 4). As expected (Sciaky et al., 1997), cells
treated with BFA alone showed numerous thin Golgi-de-
rived tubules, which after a few minutes irreversibly fused
with the ER, leading to the disappearance of Golgi fluores-
cence (Figure 4A; Supplementary Video 1). Propanolol not
only reduced the density of BFA-induced tubules emerging
from the Golgi but also increased their diameter (compare
Figure 4A, panel 7 with 4B, panel 10, arrow; also compare
Supplementary Video 1 with Supplementary Video 2).
Moreover, the few thick tubules produced by BFA in the
presence of propanolol grew in length but failed to fuse with
the ER, with most returning to the Golgi (white arrow in
Figure 4B; Supplementary Video 2). U73122-treated cells
also showed a significant slowing-down of the BFA-induced
Golgi tubulation process but tubules were similar to those
seen after BFA treatment alone. As observed in propanolol-
treated cells, they also remained in the cytoplasm for longer
(unpublished data). Hence, the decelerated Golgi disassem-
bly induced by BFA in propanolol- or U73122-treated cells
was not caused by an alteration in the kinetics of coatomer
dissociation from Golgi membranes. Rather, both agents
interfered with the formation and the progress of Golgi-
derived tubules and/or their subsequent fusion with the ER.
DOG and PDBu prevented the Propanolol/U73122-induced
Inhibition of Retrograde Transport of KDELr
To establish a direct link between the effects of propanolol or
U73122 on ER–Golgi interface membrane trafficking and the
decrease of DAG pool in the Golgi, we examined whether
these trafficking alterations would be prevented by the ex-
ogenous resupplementation of the DAG pool. We used short
acyl chain DOG and the DAG analogue PDBu. Control
experiments demonstrated that neither DOG (3 M) nor
PDBu (250 nM) altered the actin or microtubule cytoskeleton
(unpublished data). We next checked that DOG and PDBu
are indeed incorporated into Golgi membranes. We took
advantage of the fact that DAG pools are recognized by
proteins that contain a conserved sequence of 50 amino acids,
the so-called C1 domain (Colo´n-Gonza´lez and Kazanietz,
2006). This is the case of PKC, whose C1b domain behaves
as a sensor of DAG (Quest et al., 1994). When cells were
transfected with the GFP-C1 domain and treated with phor-
bol myristate acetate (PMA, a hydrophobic DAG analogue
that it is preponderantly incorporated into the plasma mem-
brane), the GFP-C1 domain in the Golgi (Figure 5, B and E)
was reduced (Figure 5A), because it was quickly redistrib-
uted to the plasma membrane (Figure 5, C and F; Supple-
mentary Video 3) as previously reported in other cell types
(Carrasco and Merida, 2004). Less than 20% of Golgi-asso-
ciated GFP-C1b domain fluorescence in PMA-treated cells
remained at the Golgi after 5–10 min of PMA treatment
(Figure 5A). At longer times, the fluorescence rose very
slowly (Figure 5A; Supplementary Video 3). On this basis,
we added DOG or PDBU at the moment at which the Golgi-
associated GFP-C1b fluorescence was the lowest (between 5
and 10 min after PMA treatment). We expected to see a
Figure 4. Propanolol impairs both the formation of normal BFA-induced Golgi-derived tubules and their subsequent fusion to the ER. Time
series of fluorescent images taken from films of HeLa cells constitutively expressing YFP-GalTase during the Golgi disassembly induced by
BFA (5 g/ml; A) or propanolol (60 M) plus BFA (B). BFA induced the formation of thin YFP-GalTase–containing tubules emerging from
the Golgi (5- and 7-min frames). Subsequently, tubules fused with the ER, giving rise to the characteristic ER-like staining pattern (10-min
frame). In contrast, propanolol pretreatment prevented BFA-induced Golgi disassembly (B). After 25 min of propanolol plus BFA treatment,
the Golgi was still clearly visible (B) and a representative large, thick tubule emerging from the bottom of the Golgi was seen to grow and
then retract into the Golgi. Videos corresponding to frames shown in A were obtained from Supplementary Video 1 (YFP-GalTase HeLa cells
plus BFA) and those shown in B were from Supplementary Video 2 (YFP-GalTase HeLa cells propanolol plus BFA).
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faster relocation of the GFP-C1b domain from the plasma
membrane back to the Golgi due to the incorporation of
DOG and PDBU into intracellular membranes. Thus, when
DOG or PDBU was added to PMA-treated cells, the GFP-
C1b fluorescence was indeed viewed in the Golgi much
earlier than in cells treated with PMA alone (Figure 5A;
compare Figure 5D with 5G and Supplementary Video 3,
PMA, with Supplementary Video 4, PMADOG). There-
fore, this result indicates that DOG and PDBu added to
intact cells efficiently pass the plasma membrane and reach
the Golgi complex.
Next, we tested whether DOG and PDBu could counteract
the effects on membrane traffic produced by propanolol and
U73122. We first examined whether DOG (Figure 6) and
PDBu (unpublished data) were able to compensate the pro-
panolol/U73122-induced decrease of DAG in the Golgi. We
monitored the dynamics of the GFP-C1b domain in the
Golgi (Figure 6). Propanolol induced a substantial decrease
in Golgi-associated GFP-C1b fluorescence (Figure 6, A and
B; Supplementary Video 5) in agreement with reduced Golgi
binding of PKD-KD (Figure 1A) and reduced levels of DAG
in the Golgi (Figure 1I). In the same way, cells treated with
FB1 did not show, at steady state, the characteristic Golgi
localization of the GFP-C1 domain, which was redistributed
to the cytoplasm (Supplementary Figure 3B). When DOG
was added before propanolol, the decrease in fluorescence
was significantly attenuated (Figure 6, A and B; Supplemen-
tary Video 6). DOG alone did not alter the Golgi localization
of the C1 domain (Figure 6, A and B). Taken together, these
results indicate that DOG and PDBu are incorporated into
the Golgi and compensate for the propanolol-induced de-
crease of Golgi-associated endogenous DAG. Thereafter, we
Figure 5. DOG and PDBu are incorporated in the Golgi. (A) Cos-1
cells were transiently transfected with the vector expressing the
GFP-C1b domain of PKC. Subsequently, the GFP-C1 domain dy-
namics at the Golgi was examined after PMA treatment (250 nM/30
min) by confocal fluorescence microscopy. PMA induced a quick
decrease of the Golgi-associated GFP fluorescence after 5–10 min,
after which the Golgi-associated fluorescence recovered very slowly
(Supplementary Video 3). When cells were treated with DOG (3
M) or PDBu (250 nM) after 10 min of PMA treatment (see Supple-
mentary Video 4 for a representative PMA  DOG experiment),
recovery of the Golgi-associated C1 domain fluorescence was much
faster than that seen in PMA-treated cells alone. DOG was more
efficient than PDBU in the Golgi relocation of the C1 domain. (B–G)
Fluorescent images taken from representative experiments (shown
in A), corresponding to cells treated with PMA alone (B–D; see
Supplementary Video 3) and PMA plus DOG (E–G; Supplementary
Video 4). At steady state, the GFP-C1 domain was almost exclu-
sively localized to the Golgi (B and E), but it was shifted to the
plasma membrane after 10 min of PMA treatment (C and F)
where it remained for at least 30 min (D). DOG (3 M) addition
after 10 min of PMA induced a much faster return of GFP-C1 to
the Golgi (arrows in G) in comparison to cells treated with PMA
(D). Bar, 10 m.
Figure 6. DOG attenuates the propanolol-induced release of the
C1 domain from the Golgi. (A) Cos-1 cells transiently expressing
GFP-C1b PKC were examined for the GFP-C1b domain dynamics at
the Golgi after propanolol (60 M), DOG (3 M), and DOG plus
propanolol treatments using in vivo confocal fluorescence micros-
copy. Propanolol treatment induced partial and transient redis-
tribution of the GFP-C1 domain from the Golgi to the cytosol
(Supplementary Video 5). DOG treatment alone did not affect
Golgi-associated fluorescence of the C1 domain (unpublished
data) but DOG pretreatment significantly prevented the propano-
lol-induced GFP-C1 cytosolic shift (Supplementary Video 6). (B)
Quantitative analysis of the Golgi-associated GFP-C1 fluores-
cence in cells (n 	 8) after 5 min of each treatment. Statistical
significance, *p 	 0.05 and **p 	 0.01.
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tested whether DOG or PDBu prevented the alterations
caused by propanolol (Figure 7) or U73122 (unpublished
data) in the retrograde protein trafficking. Cells were simul-
taneously incubated with DOG or PDBu plus propanolol or
U73122, and the subcellular distribution of KDELr was ex-
amined. As shown in Figure 7, the staining pattern of KDELr
in DOG or PDBu plus propanolol-treated cells was appar-
ently indistinguishable from control (compare Figure 7, E
and F, with 7A). Neither DOG nor PDBu alone altered the
KDELr distribution (Figure 7, B and C). DOG (Supplemen-
tary Figure 6) and PDBu (unpublished data) also signifi-
cantly counteracted the inhibition of BFA-induced Golgi
disassembly in propanolol- or U73122-treated cells. Overall,
our results show that exogenously added DAG efficiently
compensates for the decrease in endogenous DAG in the
Golgi and prevents the alterations in Golgi-to-ER membrane
traffic induced by propanolol and U73122.
DOG and PDBu Prevented Cisternae Swelling and the
Abnormally High Density of Golgi-associated Buds
Produced by Propanolol and U73122
We examined the ultrastructure of the Golgi complex in
Vero (Figure 8), NRK (Figure 9), and HeLa (unpublished
data) cells treated with propanolol and U73122 despite that
by immunofluorescence the Golgi complex remained appar-
ently unaltered (Figure 2). Conventional TEM analysis indi-
cates that propanolol (Figures 8B and 9B) and U73122 (Fig-
ure 8C) both induce fragmentation of Golgi cisternae,
whereas propanolol treatment also results in cisternal swell-
ing. Notably, both agents gave rise to numerous coated
membranes in close vicinity of Golgi cisternae, which,
judged by their ultrastructure and localization, carried a
COPI coat (Figures 8B and 9B, propanolol, arrowheads and
insets; Figure 8C, U73122, arrowheads; Table 1). In control
cells, these Golgi-associated circular profiles were almost
undetectable (Figures 8A and 9A; Table 1). In conventional
TEM analysis of ultrathin (50–70 nm) sections, circular
membrane profiles cannot be assigned unequivocally to free
transport carriers (vesicles) because they might also corre-
spond to cross-sectioned membrane tubules or buds. How-
ever, such an analysis is possible using thicker sections
(250 nm) and electron tomography. Tomograms of pro-
panolol-treated cells (Supplementary Video 7) clearly indi-
cated that cisternae were swollen and carried an abnormally
high number of membrane buds attached to the cisterna
through a narrow neck (see contoured structures in Figure
9C). 3D models of these tomograms confirmed the presence
of numerous nascent transport carriers that appeared to be
arrested before membrane fission (vesicles colored in red in
Figure 9D, 1–3; Supplementary Video 8) and that carried a
characteristic electron-dense fuzzy COPI coat (Figures 8B
and 9B, arrowheads and insets, and 9C; Supplementary
Figure 7. DOG and PDBu prevent the propanolol-
induced alteration of the subcellular distribution of the
KDELr. Vero cells were treated for 1 h with DOG (3 M;
B), PDBu (250 nM; C), propanolol (60 M; D), DOG plus
propanolol (E), or PDBu plus propanolol (F). Thereafter,
cells were fixed and stained for KDELr. As shown in
Figure 3, at steady state, the KDELr was located in the
Golgi and in numerous punctated cytoplasmic struc-
tures (A). This staining pattern was not altered by DOG
(B) or PDBu (C) treatments. Propanolol decreased the
fluorescent punctate cytoplasmic structures, revealing a
more Golgi-like staining pattern (D). When DOG (E) or
PDBU (F) was added with propanolol, the resulting
subcellular distribution of the KDELr was practically
indistinguishable from control (A). (G) Quantitative
analysis of the percentage of fluorescent punctate cyto-
plasmic structures in each experimental condition (A–
F). Statistical significance, *p 	0.05, **p 	 0.01, and
***p 	 0.001. Bar, 10 m.
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Video 7). Next, we tested whether DOG and PDBu pre-
vented these Golgi ultrastructural alterations. Thus, DOG or
PDBU were added 10 min before propanolol and, after 15
min of treatment, cells were processed for TEM. The Golgi
ultrastructure in DOG plus propanolol- or U73122-treated
cells (Figure 8E and F, respectively) was indistinguishable
from that of control cells (Figure 8A). Similar results were
obtained with PDBu (unpublished data). Importantly, nei-
ther DOG alone (Figure 8D) nor PDBu alone (unpublished
data) produced any alteration in the Golgi organization.
Stereological analysis (Table 1) indicates that propanolol
increased the Golgi membrane surface area (as expected in a
swelling process), whereas both propanolol and U73122 in-
creased the density of peri-Golgi located round profiles. In
contrast, there were no significant differences in any stereo-
logical parameter when control cells were compared with
cells treated with DOG plus propanolol (Table 1). Overall,
the ultrastructural analysis strongly suggests that propano-
lol and U73122 interfere with the fission process of Golgi-
derived COPI-coated transport carriers resulting in an ab-
normally high number of Golgi-associated budding profiles.
Moreover, this apparent arrest in membrane fission can be
prevented by DOG and PDBu pretreatments.
The Decrease of the Golgi-associated DAG Pool Reduced
ARFGAP1 But Not CtBP3/BARS in Golgi Membranes
Recent studies stress the importance of ARFGAP1 and
CtBP3/BARS in COPI vesicle formation (Yang et al., 2005).
In an attempt to examine functional coupling between DAG
and CtBP3/BARS, Vero cells were first treated with pro-
panolol and then permeabilized with streptolysin O (SLO) to
remove most of the nuclear and cytoplasmic pools of
CtBP3/BARS and facilitate its detection at the Golgi (Sup-
plementary Figure 7A). Neither propanolol (Supplementary
Figure 7B) nor U73122 (unpublished data), nor both agents
added together decreased the Golgi-associated CtBP3/BARS
pool (Supplementary Figure 7C). Next, we tested the Golgi-
localized protein ARFGAP1, which controls the formation of
the COPI-coated transport carriers at the ER–Golgi interface
(Yang et al., 2002; Bigay et al., 2003; Lee et al., 2005) and
whose activation seems to be partially dependent on DAGs
(Antonny et al., 1997). As expected, GFP-ARFGAP1 was
almost exclusively seen in the Golgi (Figure 10A). The ex-
pression of GFP-ARFGAP1 did not alter the Golgi localiza-
tion of either -COP or CtBP3/BARS (unpublished data).
We then monitored the dynamics of GFP-ARFGAP1 by in vivo
Figure 8. Propanolol and U73122 induce a
high density of COPI buds, which is counter-
acted by DOG and PDBu. Control (A), pro-
panolol (60 M; B)-, and U73122 (6 M; C)-
treated Vero cells were fixed and processed
for conventional transmission electron mi-
croscopy (TEM). Normal Golgi stacks con-
tained tightly attached 4–6 flat cisternae with
a small number of peri-Golgi tubulovesicular
profiles (A). Propanolol (B) and U73122 (C)
treatments increased the number of peri-Golgi
vesicular elements around swollen cisternae
in the case of propanolol (B) or smaller cister-
nae in the case of U73122 (C). Both treatments
induced vesicle-budding profiles containing
an electron-dense coat that is characteristic of
the COPI complex (arrowheads in B and C,
and inset in B). Cells treated with DOG alone
(3 M; D) or pre-treated with DOG before pro-
panolol (E) or U73122 (F) treatments showed a
Golgi organization that was indistinguishable
from control (A). Bar, 200 nm.
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confocal microscopy. Propanolol reduced GFP-ARFGAP1 in
the Golgi by 50% (Figures 10, B and C; Supplementary
Video 9). U73122 treatment led to a milder reduction (unpub-
lished data). Pretreatment with DOG significantly offset this
decrease (Figure 10, B and C; Supplementary Video 10).
DOG alone did not alter the Golgi localization of GFP-
ARFGAP1 (Figure 10, B and C). Therefore, data indicate that
DAG directly participates in the functional recruitment of
ARFGAP1 to the Golgi.
DISCUSSION
The current study shows that a decrease in DAG at the Golgi
affects retrograde (Golgi-to-ER) but not anterograde (ER-to-
Golgi) membrane transport. Reducing Golgi DAG decreases
the dynamic interaction of ARFGAP1 with Golgi mem-
branes and causes a blockade in the formation of COPI-
coated vesicles. Our experimental evidence is based on the
use of propanolol and U73122, two compounds that are
known to diminish cellular DAG content. We demonstrate that
both drugs significantly reduce Golgi-associated DAG levels,
and, in addition, that PKD-KD and the C1b-PKC domain (two
established reporters for DAG) redistribute from the Golgi to
the cytosol. It is important to note that propanolol and U73122
were used at relatively low concentrations (60 and 6 M,
respectively), lower than the usual concentrations used in
pharmacological studies (Stiles et al., 1984). Our conclusion that
a decrease in DAG impairs retrograde transport is supported
by the finding that both DOG and PDBU counteract the effects
of propanolol and U73122 treatments.
Figure 9. Electron tomography reveals that
propanolol arrested COPI-coated transport
carriers during fission from Golgi cisternae.
Untreated (A) and propanolol (60 M; B–D)-
treated NRK cells were processed for TEM. As
observed in Vero cells (Figure 8), propanolol
induced cisternae swelling, and COP-coated
vesicular profiles both closely localized and
attached to cisternae. The latter is easily seen
because of the formation of a narrow neck
between the transport carrier and the cisterna
(arrowheads). Two representative COPI-coated
budding vesicles are shown in the inset. (C)
Consecutive 6-nm-thick virtual slices extracted
from the tomogram. (D) 3D modeling generated
by manual segmenting of the tomographic data
shown in C. Cisternae are shown in blue, COP-
coated round profiles attached to cisternae in
red and fully isolated vesicles in green. D2 panel
is the same as D1, but it has been laterally ro-
tated 45° about the X axis. D3 panel is an en-
largement of a zone shown in the adjacent other
two panels, to show a better view of the numer-
ous vesicles attached (red) to the lateral rims of
cisternae (blue). Original tomogram plus seg-
mented contours together with the modeled
data derived from the 3D reconstruction can be
viewed in Supplementary Videos 7 and 8, re-
spectively. Videos allow better visualization of
the connections between COP-coated vesicles
and cisternae in propanolol-treated cells. Bar,
200 nm.
Table 1. Stereological analysis of the Golgi complex in NRK cells
Vcist-G (%)a Scist-G (m1)b Nves-G (m3)c Nbud (n)d
Control 36.7  2.3 16.0  3.0 267.0  33.3 1.1  0.4
Propanolol 40.7  3.0**e 20.2  4.0* 592.8  45.5*** 4.0  1.0***
U73122 38.2  1.2 17.4  1.5 496.3  57.9*** 3.0  0.7***
DOG 37.1  2.0 15.8  1.2 286  34 1.0  0.6
DOG  propanolol 38.1  3.3 17.1  2.0 301  40 1.3  0.6
DOG  U73122 37.3  2.7 16.1  1.9 281  62 1.1  0.4
a Vcist-G, volume density.
b Scist-G, surface density of cisternae.
c Nves-G, numerical density of peri-Golgi vesicle profiles.
d Nbud, number of Golgi buds per m2.
e Statistical significance: *p 	 0.05, **p 	 0.01, ***p 	 0.001.
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DAG and Membrane Traffic at the ER–Golgi interface
Our results of the ER-to-Golgi VSV-G transport and the Golgi
reassembly after the BFA washout indicate that the early an-
terograde (ER-to-Golgi) protein transport is not dependent on
the DAG pool(s) decreased by propanolol, U73122, or FB1.
Conversely, unlike FB1, both propanolol and U73122 impair
retrograde (Golgi-to-ER) protein transport, as shown by the
delay in the BFA-induced Golgi disassembly and by the con-
sistent change in the subcellular distribution of the KDELr,
which led to a Golgi-like staining pattern. This is indicative that
KDELr is retained in the Golgi. Importantly, DOG or PDBU,
which are incorporated to the Golgi, prevented the propano-
lol/U73122-induced morphological alterations, which strongly
indicates that such alterations were caused by the reduction of
the Golgi-associated DAG pool(s). It is tempting to speculate
that propanolol, U73122, and FB1 all reduce Golgi-associated
DAG, but they probably affect different DAG pools, ex-
plaining why propanolol has more pronounced effects on
Golgi-to-ER traffic than U73122, whereas FB1 reduces
Golgi DAG without any measurable effect on Golgi-to-ER
traffic. This hypothesis can also be extrapolated to late
Golgi compartments because VSV-G post-Golgi transport
is blocked by FB1 but not by U73122, suggesting that as at
the ER–Golgi interface, different DAG pools participate in
formation of TGN-derived transport carriers. Therefore, it
would be very informative to find out whether transport
carriers derived from different Golgi compartments (cis-
and trans-TGN) are specifically associated with different
molecular species of DAG. In turn, this could also deter-
mine the particular fission molecular machinery recruit-
ment at each Golgi compartment required to generate
specific transport carriers (see below). In any case, we
cannot exclude other possibilities to explain the different
membrane trafficking sensitivity to these agents such as
that the same DAG species are present at several Golgi
compartments but in different membrane contexts (for
instance, different rate of cholesterol and/or other neigh-
bor lipids) and/or that the targeted enzymes are merely
localized in different Golgi compartments.
Role of DAG in the Fission of COPI Transport Carriers
Ultrastructural analysis of the Golgi architecture in propano-
lol/U73122-treated cells clearly shows the accumulation of
COPI-coated vesicle profiles next to Golgi cisternae. Electron
tomography and 3D modeling showed a preponderance of
COPI-coated vesicle buds, which indicates that the decrease
of Golgi-associated DAG levels caused by propanolol and
U73122 impairs the membrane scission of COPI-coated
transport carriers from the cisterna. The numerous budding
profiles seen in treated cells are consistent with the postu-
lated role of DAG as a lipid participating in neck formation
in a Golgi-derived vesicle or tubule (Shemesh et al., 2003),
regardless whether originating from the TGN (Bard and
Malhotra, 2006) or from an early Golgi compartment (our
results here). This structural role is assigned on the basis of
the fact that DAG has a much smaller head group than other
lipids turning into a lipid with a pronounced cone shape.
Consequently, DAG reduces the lipid head group packing
and creates membrane insertion sites, allowing peripheral
membrane proteins (such as ARFGAP1, see below) to access
the central, hydrophobic portion of the bilayer, where they
may subsequently trigger the generation of membrane cur-
vature (Nie and Randazzo, 2006). Thus, a reduction in DAG
levels of Golgi membranes would be expected to result in a
more tightly packed membrane surface, and reduce the ef-
ficiency of, or even inactivate, the molecular machinery re-
quired to induce membrane fission. What may mark the
difference between the TGN- and the early Golgi-derived
transport carrier formation is the different type of DAG
generated in each compartment and, consequently, the fis-
sion-associated molecular machinery recruited to each site.
In accordance with this postulate, we could explain the
different membrane trafficking results obtained using FB1 in
the TGN (where it blocks post-Golgi protein transport;
Baron and Malhotra, 2002) or at the ER–Golgi interface (no
alteration; present results). The latter suggests that the DAG
Figure 10. Propanolol decreased GFP-ARFGAP1 in the Golgi com-
plex. COS-1 cells were transiently transfected with a plasmid coding
for GFP-ARFGAP1, which colocalizes with the Golgi marker
CTR433 (A; asterisks indicate transfected cells). (B) Golgi-associated
GFP fluorescence measurement from ARFGAP1 of transfected cells
after propanolol (60 M) or DOG (3 M) plus propanolol treat-
ments. Propanolol lowered the amount of ARFGAP1 in the Golgi by
50% for at least 30 min (Supplementary Video 9). DOG pretreat-
ment significantly mitigated this reduction (Supplementary Video
10) and DOG alone did not affect the Golgi-associated fluorescence
of ARFGAP1 (unpublished data). Bar, 10 m. (C) Quantitative
analysis of the Golgi-associated GFP-ARFGAP1 fluorescence mea-
sured in cells (n 	 8) after 5 min of each treatment. Statistical
significance, **p 	 0.01 and ***p 	 0.001.
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derived from the Golgi-localized SM synthase 1 (Huitema et
al., 2004) could only be involved in post-Golgi trafficking. On
the other hand, the mechanical role of DAG may also be
tightly associated with the recruitment and activation of
membrane-deformation and fission-scaffold proteins in-
volved in the COPI-coated transport carriers, as reported for
noncoated carriers in the TGN (Bard and Malhotra, 2006).
Thus, the induced decrease of Golgi-associated DAG pool
triggers the cytosolic redistribution of a significant amount
of the Golgi-associated ARFGAP1 pool, which in turn is
crucial to coatomer assembly and the subsequent deforma-
tion of Golgi-derived transport carriers (Bigay et al., 2003;
Liu et al., 2005). Note that despite the decrease of ARFGAP1
in the Golgi, the localization of coatomer (reported by
-COP) and CtBP3/BARS was unaltered. In accordance
with the former, EM images show numerous buds fully
covered with the characteristic COPI coat. This result is not
surprising because although ARFGAP1 and CtBP3/BARS
interact directly in the COPI coat, they are recruited to the
Golgi independently (Yang et al., 2005). Furthermore, pre-
treatment with DOG significantly mitigated the propanolol-
induced release of ARFGAP1 from Golgi membranes in
vivo. Therefore, our results indicate that DAG is required to
recruit ARFGAP1 to early Golgi compartments and thus
needed for the fission of COPI-coated transport carriers.
Conversely, it is much less clear why the BFA-stimulated
(COPI-independent) tubule-mediated retrograde trafficking
was also inhibited by propanolol and U73122. Interestingly,
very similar results were also obtained with phospholipase
A2 (PLA2) antagonists (Figueiredo et al., 1999). However, we
can only speculate that similar lipid-dependent changes in
membrane curvature could be generated by DAG and PLA2-
derived lipids to explain tubule formation at the Golgi.
Finally, DAG may also be involved in membrane fusion
events at the ER–Golgi interface. In this respect, we empha-
size the continuous but erratic back-and-forth movement of
abnormal BFA-induced Golgi-derived tubules in propano-
lol- and U73122-treated cells (at least in those cells that
showed BFA-induced tubulation). This observation sug-
gested, first, that BFA-induced tubules in propanolol/
U73122-treated cells were abnormally formed, but the delay
in the Golgi disassembly could also be attributable to defec-
tive fusion of these tubules with ER membranes. However,
the finding that the Golgi was normally disassembled when
propanolol or U73122 was added after BFA suggests that the
primary cause was not defective membrane fusion. If that
were the case, the Golgi disassembly should be equally
affected regardless of whether propanolol or U73122 was
added before, after, or at the same time as BFA.
In summary, our data indicate that DAG is required for the
formation of COPI transport carriers at early Golgi compart-
ments because it facilitates the recruitment of ARFGAP1. In
addition, the results also suggest that different DAG moieties
could be determinant in the specific recruitment of protein
complexes directly responsible for sorting and/or membrane
fission events in different Golgi compartments.
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